Figure 5

Prognosis of patients classified into the high and low MIR31 groups. Kaplan–Meier curves depicting the progression-free survival (PFS). *p < 0.05, log-rank test.
Prognosis of patients classified into the high and low MIR31 groups. Kaplan–Meier curves depicting the progression-free survival (PFS). *p < 0.05, log-rank test.